J Leg Med. 2020 Jul-Dec;40(3-4):335-353. doi: 10.1080/01947648.2020.1868940.
In the 10 years that the U.S. Food and Drug Administration (FDA) has been regulating tobacco products, the agency has been plagued with setbacks, some of its own making, and some the result of outside forces. What has been consistently true is that the public health community has not had as much of a voice as it should have until public health groups began filing lawsuits against the FDA. This article examines four areas of FDA regulation over the last decade in an attempt to qualitatively describe the work of the Center for Tobacco Products and identify opportunities for public health groups to have greater advocacy success in the future.
在过去的十年里，美国食品和药物管理局（FDA）一直在监管烟草产品，但该机构一直受到挫折的困扰，有些是自身造成的，有些则是外部力量的结果。一直以来，公共卫生界的声音都没有得到应有的重视，直到公共卫生组织开始对 FDA 提起诉讼。本文通过对 FDA 在过去十年中监管的四个领域进行定性描述，试图探讨中心烟草产品的工作，并确定公共卫生组织在未来获得更大倡导成功的机会。
